Published in Menopause on January 01, 2016
Menopause down under: lessons for clinicians everywhere. Menopause (2016) 0.75
Urinary incontinence in young nulligravid women: a cross-sectional analysis. Ann Intern Med (2012) 3.34
Circulating androgen levels and self-reported sexual function in women. JAMA (2005) 2.40
Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab (2010) 2.27
Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat (2011) 2.18
Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause (2006) 2.07
Incidence of total knee and hip replacement for osteoarthritis in relation to circulating sex steroid hormone concentrations in women. Arthritis Rheumatol (2014) 2.05
Sexual function after breast cancer. J Sex Med (2010) 1.89
Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause (2015) 1.71
Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause (2007) 1.70
Hormone replacement therapy: current controversies. Clin Endocrinol (Oxf) (2003) 1.64
Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause (2003) 1.62
The cross-sectional relationship between fortnightly exercise and knee cartilage properties in healthy adult women in midlife. Menopause (2007) 1.53
Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis. Menopause (2014) 1.46
The incidence of invasive breast cancer among women prescribed testosterone for low libido. J Sex Med (2009) 1.42
Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis. Menopause (2013) 1.41
A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology (2005) 1.36
Treatment of menopausal symptoms: what shall we do now? Lancet (2005) 1.35
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab (2003) 1.27
Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab (2007) 1.14
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause (2006) 1.09
Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. Int J Urol (2008) 1.06
Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf) (2007) 1.06
Letter to the editor: Randolph J, et al. Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition. J Clin Endocrinol Metab (2015) 1.05
Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med (2008) 1.05
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2014) 1.02
Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology (2010) 1.02
Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users. Contraception (2009) 1.01
Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J (2002) 1.00
Age-specific prevalence of, and factors associated with, different types of urinary incontinence in community-dwelling Australian women assessed with a validated questionnaire. Maturitas (2009) 1.00
Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev (2004) 0.99
Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause (2005) 0.99
Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther (2009) 0.98
Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence. J Sex Med (2012) 0.95
Compartment differences in knee cartilage volume in healthy adults. J Rheumatol (2002) 0.95
DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update (2007) 0.94
Urinary incontinence is associated with lower psychological general well-being in community-dwelling women. Menopause (2010) 0.93
What do obstetricians think about media influences on their patients? Aust N Z J Obstet Gynaecol (2006) 0.92
Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas (2005) 0.92
Static knee alignment is associated with the risk of unicompartmental knee cartilage defects. J Orthop Res (2008) 0.91
Endocrine aspects of women's sexual function. J Sex Med (2010) 0.90
High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther (2008) 0.89
Factors identified during the neonatal period associated with risk of cerebral palsy. Aust N Z J Obstet Gynaecol (2004) 0.89
Greater superior than inferior parietal lobule activation with increasing rotation angle during mental rotation: an fMRI study. Neuropsychologia (2009) 0.89
Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis. Menopause (2013) 0.87
Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women. J Womens Health (Larchmt) (2008) 0.86
The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas (2009) 0.86
Negative beliefs about low back pain are associated with high pain intensity and high level disability in community-based women. BMC Musculoskelet Disord (2008) 0.86
The natural history of bone marrow lesions in community-based middle-aged women without clinical knee osteoarthritis. Semin Arthritis Rheum (2008) 0.86
Prevalence of fecal incontinence and its relationship with urinary incontinence in women living in the community. Menopause (2011) 0.85
Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas (2011) 0.85
A pragmatic approach to the classification of menopausal status for community-based research. Menopause (2008) 0.85
Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40-65 years. Med J Aust (2015) 0.84
Testosterone insufficiency in women: fact or fiction? World J Urol (2002) 0.84
Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC Cancer (2008) 0.84
Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer. Menopause (2010) 0.83
Low back pain and disability in community-based women: prevalence and associated factors. Menopause (2009) 0.83
The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer. Fam Cancer (2009) 0.83
DHEA for postmenopausal women: a review of the evidence. Maturitas (2010) 0.83
Determinants of change in patella cartilage volume in healthy subjects. J Rheumatol (2006) 0.82
Androgens in women. J Steroid Biochem Mol Biol (2003) 0.82
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med (2008) 0.82
Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause (2013) 0.82
The relationship between the knee adduction moment and knee pain in middle-aged women without radiographic osteoarthritis. J Rheumatol (2006) 0.82
The prevalence of vitamin D deficiency and relationship with fracture risk in older women presenting in Australian general practice. Australas J Ageing (2011) 0.81
Breast cancer survivors' beliefs about the causes of breast cancer. Psychooncology (2011) 0.81
Osteoarthritis and the postmenopausal woman: Epidemiological, magnetic resonance imaging, and radiological findings. Semin Arthritis Rheum (2004) 0.81
Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia. Support Care Cancer (2013) 0.81
Postmenopausal testosterone therapy and breast cancer risk. Maturitas (2004) 0.81
Cervical surveillance as an alternative to elective cervical cerclage for pregnancy management of suspected cervical incompetence. Aust N Z J Obstet Gynaecol (2004) 0.81
What is the rationale for androgen therapy for women? Treat Endocrinol (2003) 0.81
Consequences of surveying folate awareness. Health Expect (2002) 0.81
The associations between the dominant and nondominant peak external knee adductor moments during gait in healthy subjects: evidence for symmetry. Arch Phys Med Rehabil (2009) 0.81
Androgenic hormones and aging--the link with female sexual function. Horm Behav (2011) 0.81
Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women. Menopause (2006) 0.80
Validity and cultural equivalence of the standard Greene Climacteric Scale in Hong Kong. Menopause (2010) 0.80